Masimo PE Ratio 2010-2025 | MASI
Current and historical p/e ratio for Masimo (MASI) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Masimo PE ratio as of June 06, 2025 is 34.39.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Masimo PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-06 | 171.97 | 0.00 | |
| 2025-03-31 | 166.60 | $-9.17 | 0.00 |
| 2024-12-31 | 165.30 | $-5.70 | 0.00 |
| 2024-09-30 | 133.33 | $1.45 | 91.95 |
| 2024-06-30 | 125.94 | $1.47 | 85.67 |
| 2024-03-31 | 146.85 | $1.47 | 99.90 |
| 2023-12-31 | 117.21 | $1.51 | 77.62 |
| 2023-09-30 | 87.68 | $1.64 | 53.46 |
| 2023-06-30 | 164.55 | $2.14 | 76.89 |
| 2023-03-31 | 184.54 | $2.18 | 84.65 |
| 2022-12-31 | 147.95 | $2.60 | 56.90 |
| 2022-09-30 | 141.16 | $3.02 | 46.74 |
| 2022-06-30 | 130.67 | $3.32 | 39.36 |
| 2022-03-31 | 145.54 | $3.87 | 37.61 |
| 2021-12-31 | 292.78 | $3.98 | 73.56 |
| 2021-09-30 | 270.71 | $4.01 | 67.51 |
| 2021-06-30 | 242.45 | $3.86 | 62.81 |
| 2021-03-31 | 229.66 | $3.94 | 58.29 |
| 2020-12-31 | 268.38 | $4.14 | 64.83 |
| 2020-09-30 | 236.06 | $3.85 | 61.31 |
| 2020-06-30 | 227.99 | $3.86 | 59.06 |
| 2020-03-31 | 177.12 | $3.69 | 48.00 |
| 2019-12-31 | 158.06 | $3.44 | 45.95 |
| 2019-09-30 | 148.79 | $3.35 | 44.41 |
| 2019-06-30 | 148.82 | $3.51 | 42.40 |
| 2019-03-31 | 138.28 | $3.51 | 39.40 |
| 2018-12-31 | 107.37 | $3.46 | 31.03 |
| 2018-09-30 | 124.54 | $2.64 | 47.17 |
| 2018-06-30 | 97.65 | $2.32 | 42.09 |
| 2018-03-31 | 87.95 | $2.36 | 37.27 |
| 2017-12-31 | 84.80 | $2.36 | 35.93 |
| 2017-09-30 | 86.56 | $6.32 | 13.70 |
| 2017-06-30 | 91.18 | $6.14 | 14.85 |
| 2017-03-31 | 93.26 | $5.88 | 15.86 |
| 2016-12-31 | 67.40 | $5.59 | 12.06 |
| 2016-09-30 | 59.49 | $2.08 | 28.60 |
| 2016-06-30 | 52.52 | $1.92 | 27.35 |
| 2016-03-31 | 41.84 | $1.71 | 24.47 |
| 2015-12-31 | 41.51 | $1.56 | 26.61 |
| 2015-09-30 | 38.56 | $1.50 | 25.71 |
| 2015-06-30 | 38.74 | $1.41 | 27.48 |
| 2015-03-31 | 32.98 | $1.29 | 25.57 |
| 2014-12-31 | 26.34 | $1.30 | 20.26 |
| 2014-09-30 | 21.28 | $1.06 | 20.08 |
| 2014-06-30 | 23.60 | $1.06 | 22.26 |
| 2014-03-31 | 27.31 | $1.12 | 24.38 |
| 2013-12-31 | 29.23 | $1.01 | 28.94 |
| 2013-09-30 | 26.64 | $1.11 | 24.00 |
| 2013-06-30 | 21.20 | $1.08 | 19.63 |
| 2013-03-31 | 19.62 | $1.08 | 18.17 |
| 2012-12-31 | 21.01 | $1.07 | 19.64 |
| 2012-09-30 | 23.04 | $1.04 | 22.16 |
| 2012-06-30 | 21.33 | $1.04 | 20.51 |
| 2012-03-31 | 22.28 | $1.02 | 21.84 |
| 2011-12-31 | 17.81 | $1.04 | 17.12 |
| 2011-09-30 | 20.61 | $1.07 | 19.26 |
| 2011-06-30 | 28.28 | $1.10 | 25.71 |
| 2011-03-31 | 31.54 | $1.06 | 29.76 |
| 2010-12-31 | 27.70 | $1.21 | 22.89 |
| 2010-09-30 | 25.42 | $1.18 | 21.55 |
| 2010-06-30 | 22.17 | $1.13 | 19.62 |
| 2010-03-31 | 24.72 | $1.11 | 22.27 |
| 2009-12-31 | 26.37 | $0.89 | 29.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.324B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| Alcon (ALC) | Switzerland | $43.302B | 29.26 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| DexCom (DXCM) | United States | $33.984B | 52.53 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.054B | 5.60 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |